ArticleProceedings of the National Academy of Sciences of the United States of America2024

Successful use of anti-CD19 CAR T cells in severe treatment-refractory stiff-person syndrome.

Simon Faissner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.